ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

ConTIPI Medical has selected EVERSANA to support the U.S. commercialization of its non-surgical medical device ProVate for women with pelvic organ prolapses.
ConTIPI Medical has selected EVERSANA to support the U.S. commercialization of its non-surgical medical device ProVate for women with pelvic organ prolapses.

Originally published at https://www.prnewswire.com/news-releases/contipi-medical-selects-eversana-to-support-us-commercialization-of-non-surgical-medical-device-provate-for-women-with-pelvic-organ-prolapse-302231139.html
Images courtesy of https://pixabay.com

RELATED ARTICLESMORE FROM AUTHOR